Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group
- PMID: 2714350
- DOI: 10.1016/0277-5379(89)90216-2
Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical